277
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Rapamycin enhances dimethyl sulfoxide-mediated growth arrest in human myelogenous leukemia cells

, , &
Pages 2253-2261 | Received 04 Nov 2011, Accepted 08 Apr 2012, Published online: 21 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hrvoje Lalic, Vilma Dembitz, Vesna Lukinovic-Skudar, Hrvoje Banfic & Dora Visnjic. (2014) 5-Aminoimidazole-4-carboxamide ribonucleoside induces differentiation of acute myeloid leukemia cells. Leukemia & Lymphoma 55:10, pages 2375-2383.
Read now

Articles from other publishers (5)

Dora Visnjic, Vilma Dembitz & Hrvoje Lalic. (2019) The Role of AMPK/mTOR Modulators in the Therapy of Acute Myeloid Leukemia. Current Medicinal Chemistry 26:12, pages 2208-2229.
Crossref
Vilma Dembitz, Hrvoje Lalic & Dora Visnjic. (2017) 5-Aminoimidazole-4-carboxamide ribonucleoside-induced autophagy flux during differentiation of monocytic leukemia cells. Cell Death Discovery 3:1.
Crossref
Vilma Dembitz, Hrvoje Lalic, Alen Ostojic, Radovan Vrhovac, Hrvoje Banfic & Dora Visnjic. (2015) The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation. International Journal of Hematology 102:1, pages 12-24.
Crossref
Mohd Shazli DramanFiona Grennan-JonesLei ZhangPeter N TaylorTommy Kyaw TunJohn McDermottPaul MoriartyDaniel MorrisCarol LaneSeamus SreenanColin DayanMarian Ludgate. (2013) Effects of Prostaglandin F 2α on Adipocyte Biology Relevant to Graves' Orbitopathy . Thyroid 23:12, pages 1600-1608.
Crossref
Jessica K AltmanLeonidas C Platanias. (2013) Acute myeloid leukemia: potential for new therapeutic approaches targeting mRNA translation pathways. International Journal of Hematologic Oncology 2:3, pages 243-250.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.